N-terminal α-ketoamide peptides: Formation and transamination

Chemical Research in Toxicology

Volumn 27, Issue 4, 2014, Pages 637-648

  Lee, Seon Hwa ^a   Kyung, Hyunsook ^a   Yokota, Ryo ^a   Goto, Takaaki ^a   Oe, Tomoyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALPHA KETOAMIDE PEPTIDE; AMIDE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-11]; ASPARTIC ACID; COPPER ION; HYDROGEN; HYDROXYL RADICAL; KETONE; PEPTIDE; PYRIDOXAMINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL FUNCTIONS; ELECTROSPRAY MASS SPECTROMETRY; EPIMER; HYDROLYSIS; LIQUID CHROMATOGRAPHY; PEPTIDE SYNTHESIS; PROTEIN HYDROLYSIS; PROTEIN MODIFICATION; RADICAL REACTION; TANDEM MASS SPECTROMETRY; TRANSAMINATION; AMINATION; AMINO ACID SEQUENCE; CHEMISTRY;

AMIDES; AMINATION; AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84899434233     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx400469x     Document Type: Article

References (41)

1. Lee, S. H. and Blair, I. A. (2001) Oxidative DNA damage and cardiovascular disease Trends Cardiovasc. Med. 11, 148-155
2. Ames, B. N., Shigenaga, M. K., and Hagen, T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging Proc. Natl. Acad. Sci. U.S.A. 90, 7915-7922
3. Mangal, D., Vudathala, D., Park, J. H., Lee, S. H., Penning, T. M., and Blair, I. A. (2009) Analysis of 7,8-dihydro-8-oxo-2′-deoxyguanosine in cellular DNA during oxidative stress Chem. Res. Toxicol. 22, 788-797
4. Finkel, T. (2011) Signal transduction by reactive oxygen species J. Cell. Biol. 194, 7-15
5. Stadtman, E. R. and Berlett, B. S. (1991) Fenton chemistry. Amino acid oxidation J. Biol. Chem. 266, 17201-17211
6. Lee, S. H., Oe, T., and Blair, I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 292, 2083-2086
7. Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., and Tang, X. (2006) Protein adducts generated from products of lipid oxidation: focus on HNE and ONE Drug Metab. Rev. 38, 651-675
8. Lee, S. H. and Blair, I. A. (2011) Lipid Peroxide-DNA Adducts, in Chemical Carcinogenesis (Penning, T. M., Ed.) pp 227-244, Springer Science+Business Media LLC, New York.
9. Lee, S. H., Rindgen, D., Bible, R. H., Jr., Hajdu, E., and Blair, I. A. (2000) Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation Chem. Res. Toxicol. 13, 565-574
10. Pollack, M., Oe, T., Lee, S. H., Silva Elipe, M. V., Arison, B. H., and Blair, I. A. (2003) Characterization of 2′-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product Chem. Res. Toxicol. 16, 893-900
11. Lee, S. H., Williams, M. V., DuBois, R. N., and Blair, I. A. (2005) Cyclooxygenase-2-mediated DNA damage J. Biol. Chem. 280, 28337-28346
12. Jian, W., Lee, S. H., Williams, M. V., and Blair, I. A. (2009) 5-Lipoxygenase-mediated endogenous DNA damage J. Biol. Chem. 284, 16799-16807
13. Williams, M. V., Lee, S. H., Pollack, M., and Blair, I. A. (2006) Endogenous lipid hydroperoxide-mediated DNA-adduct formation in Min mice J. Biol. Chem. 281, 10127-10133
14. Marnett, L. J. (2000) Oxyradicals and DNA damage Carcinogenesis 21, 361-370
15. Oe, T., Lee, S. H., Silva Elipe, M. V., Arison, B. H., and Blair, I. A. (2003) A novel lipid hydroperoxide derived modification to arginine Chem. Res. Toxicol. 16, 1598-1605
16. Lee, S. H., Goto, T., and Oe, T. (2008) A novel 4-oxo-2(E)-nonenal derived modification to angiotensin II: oxidative decarboxylation of N-terminal aspartic acid Chem. Res. Toxicol. 21, 2237-2244
17. Carini, M., Aldini, G., and Facino, R. M. (2004) Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins Mass Spectrom. Rev. 23, 281-305
18. Alderton, A. L., Faustman, C., Liebler, D. C., and Hill, D. W. (2003) Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal Biochemistry 42, 4398-4405
19. Bennaars-Eiden, A., Higgins, L., Hertzel, A. V., Kapphahn, R. J., Ferrington, D. A., and Bernlohr, D. A. (2002) Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology J. Biol. Chem. 277, 50693-50702
20. Grace, J. M., MacDonald, T. L., Roberts, R. J., and Kinter, M. (1996) Determination of site-specific modifications of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal using matrix assisted laser desorption time-of-flight mass spectrometry Free Radical Res. 25, 23-29
21. Meinnel, T. and Giglione, C. (2008) Tools for analyzing and predicting N-terminal protein modifications Proteomics 8, 626-649
22. Ishii, T., Kumazawa, S., Sakurai, T., Nakayama, T., and Uchida, K. (2006) Mass spectroscopic characterization of protein modification by malondialdehyde Chem. Res. Toxicol. 19, 122-129
23. Lee, S. H., Masuda, T., Goto, T., and Oe, T. (2013) MALDI-TOF/MS-based label-free binding assay for angiotensin II type 1 receptor: application for novel angiotensin peptides Anal. Biochem. 437, 10-16
24. Kajita, R., Goto, T., Lee, S. H., and Oe, T. (2013) Aldehyde stress-mediated novel modification to proteins: epimerization of N-terminal amino acid Chem. Res. Toxicol. 26, 1926-1936
25. Foley, T. L. and Burkart, M. D. (2007) Site-specific protein modification: advances and applications Curr. Opin. Chem. Biol. 11, 12-19
26. Gilmore, J. M., Scheck, R. A., Esser-Kahn, A. P., Joshi, N. S., and Francis, M. B. (2006) N-Terminal protein modification through a biomimetic transamination reaction Angew. Chem., Int. Ed. 45, 5307-5311
27. Lee, S. H., Takahashi, R., Goto, T., and Oe, T. (2010) Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal Chem. Res. Toxicol. 23, 1771-1785
28. Culbertson, J. B. (1951) Factors Affecting the Rate of Hydrolysis of Ketimines J. Am. Chem. Soc. 73, 4818-4823
29. Zhu, X. and Sayre, L. M. (2007) Long-lived 4-oxo-2-enal-derived apparent lysine Michael adducts are actually the isomeric 4-ketoamides Chem. Res. Toxicol. 20, 165-170
30. Stadtman, E. R. and Levine, R. L. (2003) Free radical-mediated oxidation of free amino acids and amino acid residues in proteins Amino Acids 25, 207-218
31. Xu, G. and Chance, M. R. (2007) Hydroxyl radical-mediated modification of proteins as probes for structural proteomics Chem. Rev. 107, 3514-3543
32. Hawkins, C. L. and Davies, M. J. (2001) Generation and propagation of radical reactions on proteins Biochim. Biophys. Acta 1504, 196-219
33. Cesari, M., Rossi, G. P., and Pessina, A. C. (2002) Biological properties of the angiotensin peptides other than angiotensin II: Implications for hypertension and cardiovascular diseases J. Hypertens. 20, 793-799
34. Jankowski, V., Vanholder, R., van der Giet, M., Tölle, M., Karadogan, S., Gobom, J., Furkert, J., Oksche, A., Krause, E., Tran, T. N., Tepel, M., Schuchardt, M., Schlüter, H., Wiedon, A., Beyermann, M., Bader, M., Todiras, M., Zidek, W., and Jankowski, J. (2007) Mass-spectrometric identification of a novel angiotensin peptide in human plasma Arterioscler., Thromb., Vasc. Biol. 27, 297-302
35. Metzler, D. E. and Snell, E. E. (1952) Some transamination reactions involving vitamin B6 J. Am. Chem. Soc. 74, 979-983
36. Voziyan, P. A. and Hudson, B. G. (2005) Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage Cell. Mol. Life Sci. 62, 1671-1681
37. McChrisley, B., Thye, F. W., McNair, H. M., and Driskell, J. A. (1988) Plasma B6 vitamer and 4-pyridoxic acid concentrations of men fed controlled diets J. Chromatogr. 428, 5-42
38. Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., and Baynes, J. W. (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int. 61, 939-950
39. Dixon, H. B. F. (1984) N-Terminal modification of proteins J. Protein Chem. 3, 99-108
40. Oe, T., Ackermann, B. L., Inoue, K., Berna, M. J., Garner, C. O., Gelfanova, V., Dean, R. A., Siemers, E. R., Holtzman, D. M., Farlow, M. R., and Blair, I. A. (2006) Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry Rapid Commun. Mass Spectrom. 20, 3723-3735
41. Inoue, K., Garner, C., Ackermann, B. L., Oe, T., and Blair, I. A. (2006) Liquid chromatography/ tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease Rapid Commun. Mass Spectrom. 20, 911-918